0001193125-15-114451.txt : 20150331 0001193125-15-114451.hdr.sgml : 20150331 20150331172853 ACCESSION NUMBER: 0001193125-15-114451 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150331 DATE AS OF CHANGE: 20150331 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-45691 FILM NUMBER: 15740548 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KOPIN MITCHELL P CENTRAL INDEX KEY: 0001116628 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 3100 DUNDEE ROAD STREET 2: SUITE 703 CITY: NORTHBROOK STATE: IL ZIP: 60062 BUSINESS PHONE: 847 562-9030 MAIL ADDRESS: STREET 1: 3100 DUNDEE ROAD STREET 2: SUITE 703 CITY: NORTHBROOK STATE: IL ZIP: 60062 SC 13G 1 d902896dsc13g.htm SCHEDULE 13G Schedule 13G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No.     )*

 

 

OXiGENE, INC.

(Name of Issuer)

Common Stock, $.01 par value per share

(Title of Class of Securities)

691828404

(CUSIP Number)

March 20, 2015

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

a. ¨ Rule 13d-1(b)

 

b. x Rule 13d-1(c)

 

c. ¨ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

Page 1 of 7

CUSIP No. 691828404 Page 2 of 7

 

  1. 

Names of reporting persons.

 

Mitchell P. Kopin

  2.

Check the appropriate box if a member of a group (see instructions)

(a)  ¨        (b)  ¨

 

  3.

SEC use only

 

  4.

Citizenship or place of organization

 

    United States of America

Number of

shares

beneficially

owned by

each

reporting

person

with:

 5. 

Sole voting power

 

    0

6.

Shared voting power

 

    1,854,455

7.

Sole dispositive power

 

    0

8.

Shared dispositive power

 

    1,854,455

  9.

Aggregate amount beneficially owned by each reporting person

 

    1,854,455 (see Item 4)

10.

Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

 

11.

Percent of class represented by amount in Row (9)

 

    6.9% (see Item 4)

12.

Type of reporting person (see instructions)

 

    IN; HC

 

Item 1.

(a) Name of Issuer

OXiGENE, INC. (the “Issuer”)

(b) Address of Issuer’s Principal Executive Offices

701 Gateway Boulevard, Suite 210

South San Francisco, CA 94080

Item 2.

(a) Name of Person Filing

(b) Address of Principal Business Office or, if none, Residence

(c) Citizenship

This Schedule 13G is being filed on behalf of Mitchell P. Kopin, an individual who is a citizen of the United States of America (“Mr. Kopin”).

The principal business office of Mr. Kopin is 245 Palm Trail, Delray Beach, Florida 33483.

(d) Title of Class of Securities

Common stock, $.01 par value per share, of the Issuer (the “Common Stock”).

(e) CUSIP Number

691828404

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable.

Item 4. Ownership.

(a) and (b):

As of March 20, 2015, Mr. Kopin may be deemed to beneficially own 2,276,783 shares of Common Stock, which consists of (i) 30,000 shares of Common Stock held by Cranshire Capital Master Fund, Ltd. (“Cranshire Capital Master Fund”), (ii) 1,919,710 shares of Common Stock to be issued to Equitec Specialists, LLC (“Equitec”), (iii) 286,280 shares of Common Stock issuable upon exercise of a warrant held by Cranshire Capital Master Fund and (iv) 40,793 shares of Common Stock issuable upon exercise of a warrant held by Equitec, and all such shares of Common Stock represent beneficial ownership of approximately 9.9% of the Common Stock, based on (1) 20,705,514 shares of Common Stock issued and outstanding on March 20, 2015, as reported in the Form 424B5 Prospectus filed by the Issuer with the Securities and Exchange Commission on March 20, 2015, plus (2) 1,919,710 shares of Common Stock to be issued to Equitec, plus (3) 286,280 shares of Common Stock issuable upon exercise of a warrant held by Cranshire Capital Master Fund plus (4) 40,793 shares of Common Stock issuable upon exercise of a warrant held by Equitec.

The foregoing excludes: (I) an aggregate of 548,523 shares of Common Stock issuable upon exercise of other warrants held by Cranshire Capital Master Fund (the “Other Cranshire Warrants”) because each of such Other Cranshire Warrants contains a blocker provision under which the holder thereof does not have the right to exercise such Other Cranshire Warrants to the extent that such exercise would result in beneficial ownership by the holder thereof (together with the holder’s affiliates and any other persons acting as a group together with the holder or any of the holder’s affiliates) of more than 4.99% of the Common Stock and (II) 959,855 shares of Common Stock issuable upon exercise of a warrant to be issued to Equitec and 126,583 shares of Common Stock issuable upon exercise of another warrant held by Equitec (collectively, the “Other Equitec Warrants”) because each of such Other Equitec Warrants contains a blocker provision under which the holder thereof does not have the

 

Page 3 of 7

right to exercise such Other Equitec Warrants to the extent that such exercise would result in beneficial ownership by the holder thereof (together with the holder’s affiliates and any other persons acting as a group together with the holder or any of the holder’s affiliates) of more than 4.99% of the Common Stock. Without such blocker provisions, Mr. Kopin may be deemed to have beneficial ownership of 3,911,744 shares of Common Stock.

Cranshire Capital Advisors, LLC, a Delaware limited liability company (“CCA”), serves as the investment manager to Cranshire Capital Master Fund. In such capacity, CCA exercises voting and investment power over the shares of Common Stock held for the account of Cranshire Capital Master Fund. Mr. Kopin, the president, the sole member and the sole member of the Board of Managers of CCA, has voting control over CCA. As a result, subject to the blocker provisions described above, each of Mr. Kopin and CCA may be deemed to have beneficial ownership (as determined under Section 13(d) of the Securities Exchange Act of 1934, as amended) of the securities of the Issuer held by Cranshire Capital Master Fund.

Cranshire Capital Investments LLC, a Delaware limited liability company (“CCI”), owns 50% of (x) the 1,919,710 shares of Common Stock to be issued to Equitec and (y) the warrants held by or to be issued to Equitec. Consequently, CCI has voting control and investment discretion over 50% of such shares of Common Stock to be issued to Equitec and the shares of Common Stock issuable upon exercise of such warrants held by or to be issued to Equitec. Mr. Kopin, the sole manager of CCI and the sole trustee of The Mitchell P. Kopin Revocable Trust (the “Trust”), which is the sole member of CCI, also has voting control and investment discretion over 50% of such shares of Common Stock to be issued to Equitec and the shares of Common Stock issuable upon exercise of such warrants held by or to be issued to Equitec. As a result, subject to the blocker provisions described above, each of Mr. Kopin, the Trust and CCI may be deemed to have beneficial ownership (as determined under Section 13(d) of the Securities Exchange Act of 1934, as amended) of 50% of such shares of Common Stock to be issued to Equitec and the shares of Common Stock issuable upon exercise of such warrants held by or to be issued to Equitec. Additionally, Mr. Kopin has shared voting control and investment discretion over the other 50% of such shares of Common Stock to be issued to Equitec and the shares of Common Stock issuable upon exercise of such warrants held by or to be issued to Equitec. As a result, subject to the blocker provisions described above, Mr. Kopin may be deemed to have beneficial ownership (as determined under Section 13(d) of the Securities Exchange Act of 1934, as amended) over the other 50% of such shares of Common Stock to be issued to Equitec and the shares of Common Stock issuable upon exercise of such warrants held by or to be issued to Equitec.

As of the close of business on March 31, 2015, Mr. Kopin may be deemed to beneficially own 1,854,455 shares of Common Stock, which consists of (i) 1,527,382 shares of Common Stock held by Equitec, (ii) 286,280 shares of Common Stock issuable upon exercise of a warrant held by Cranshire Capital Master Fund and (iii) 40,793 shares of Common Stock issuable upon exercise of a warrant held by Equitec, and all such shares of Common Stock represent beneficial ownership of approximately 6.9% of the Common Stock, based on (1) 26,544,934 shares of Common Stock issued and outstanding on March 25, 2015, as reported in the Form 10-K filed by the Issuer with the Securities and Exchange Commission on March 30, 2015, plus (2) 286,280 shares of Common Stock issuable upon exercise of a warrant held by Cranshire Capital Master Fund plus (3) 40,793 shares of Common Stock issuable upon exercise of a warrant held by Equitec.

The foregoing excludes: (I) an aggregate of 548,523 shares of Common Stock issuable upon exercise of the Other Cranshire Warrants because each of such Other Cranshire Warrants contains a blocker provision under which the holder thereof does not have the right to exercise such Other Cranshire Warrants to the extent that such exercise would result in beneficial ownership by the holder thereof (together with the holder’s affiliates and any other persons acting as a group together with the holder or any of the holder’s affiliates) of more than 4.99% of the Common Stock and (II) an aggregate of 1,086,438 shares of Common Stock issuable upon exercise of the Other Equitec Warrants because each of such Other Equitec Warrants contains a blocker provision under which the holder thereof does not have the right to exercise such Other Equitec Warrants to the extent that such exercise would result in beneficial ownership by the holder thereof (together with the holder’s affiliates and any other

 

Page 4 of 7

persons acting as a group together with the holder or any of the holder’s affiliates) of more than 4.99% of the Common Stock. Without such blocker provisions, Mr. Kopin may be deemed to have beneficial ownership of 3,489,416 shares of Common Stock.

CCA serves as the investment manager to Cranshire Capital Master Fund. In such capacity, CCA exercises voting and investment power over the shares of Common Stock held for the account of Cranshire Capital Master Fund. Mr. Kopin, the president, the sole member and the sole member of the Board of Managers of CCA, has voting control over CCA. As a result, subject to the blocker provisions described above, each of Mr. Kopin and CCA may be deemed to have beneficial ownership (as determined under Section 13(d) of the Securities Exchange Act of 1934, as amended) of the securities of the Issuer held by Cranshire Capital Master Fund.

CCI owns 50% of (x) the 1,527,382 shares of Common Stock held by Equitec and (y) the warrants held by Equitec. Consequently, CCI has voting control and investment discretion over 50% of such shares of Common Stock held by Equitec and the shares of Common Stock issuable upon exercise of such warrants held by Equitec. Mr. Kopin, the sole manager of CCI and the sole trustee of the Trust, which is the sole member of CCI, also has voting control and investment discretion over 50% of such shares of Common Stock held by Equitec and the shares of Common Stock issuable upon exercise of such warrants held by Equitec. As a result, subject to the blocker provisions described above, each of Mr. Kopin, the Trust and CCI may be deemed to have beneficial ownership (as determined under Section 13(d) of the Securities Exchange Act of 1934, as amended) of 50% of such shares of Common Stock held by Equitec and the shares of Common Stock issuable upon exercise of such warrants held by Equitec. Additionally, Mr. Kopin has shared voting control and investment discretion over the other 50% of such shares of Common Stock held by Equitec and the shares of Common Stock issuable upon exercise of such warrants held by Equitec. As a result, subject to the blocker provisions described above, Mr. Kopin may be deemed to have beneficial ownership (as determined under Section 13(d) of the Securities Exchange Act of 1934, as amended) over the other 50% of such shares of Common Stock held by Equitec and the shares of Common Stock issuable upon exercise of such warrants held by Equitec.

(c) Number of shares as to which each Reporting Person has:

(i) Sole power to vote or to direct the vote: 0.

(ii) Shared power to vote or to direct the vote: 1,854,455.

(iii) Sole power to dispose or to direct the disposition of 0.

(iv) Shared power to dispose or to direct the disposition of 1,854,455.

 

Item 5. Ownership of Five Percent or Less of a Class

Not applicable.

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

Not applicable.

 

Item 8. Identification and Classification of Members of the Group

Not applicable.

 

Item 9. Notice of Dissolution of Group

Not applicable.

 

Page 5 of 7

Item 10. Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

 

Page 6 of 7

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: March 31, 2015

 

/s/ Mitchell P. Kopin

Mitchell P. Kopin

 

Page 7 of 7